Cunegatto-Braga Murillo, Hogan Brian, Aguilar-Salinas Pedro, Beier Alexandra D, Hanel Ricardo A
Lyerly Neurosurgery, Baptist Neurological Institute, Jacksonville, Florida, USA.
Division of Pediatric Neurosurgery, Wolfson Children's Hospital, University of Florida Health Jacksonville, Jacksonville, Florida, USA.
World Neurosurg. 2018 Sep;117:255-260. doi: 10.1016/j.wneu.2018.06.031. Epub 2018 Jun 15.
Intracranial aneurysms (IAs) are rare in the pediatric population and are usually considered difficult to treat with traditional microsurgery owing to their complex morphology. Endovascular techniques have become the standard option for treating IAs in adults. More recently, flow diverters, such as the Pipeline embolization device (PED), are being widely adopted for unruptured IAs, with proven safety and efficacy in adults; however, their use in the pediatric population is not well defined. Here we report a pediatric patient with a ruptured posterior cerebral artery (PCA) aneurysm successfully treated with a PED, and provide a review of the literature on the current status of PED use in this subset of patients.
A previously healthy 4-year old boy presented to the emergency department with a subarachnoid hemorrhage. Magnetic resonance angiography (MRA) suggested a ruptured dissecting aneurysm in the right PCA. After discussing treatment options with the child's parents, off-label use of the PED device was chosen. A single PED device was successfully deployed within 24 hours of onset. At a 6-month follow-up, the patient was fully recovered, with a modified Rankin Scale score of 0, and MRA showed complete occlusion of the aneurysm and patency of the parent vessel.
Even though the PED has not received Food and Drug Administration approval to treat IAs in children, the literature reports favorable outcomes with this application. Thus, the PED may be a feasible option for treating challenging cases occurring more frequently in the pediatric population. Further studies in pediatric populations are needed to determine whether this technology is a viable and durable option for treating aneurysms in children.
颅内动脉瘤(IAs)在儿科人群中较为罕见,由于其形态复杂,传统显微手术通常难以治疗。血管内技术已成为治疗成人颅内动脉瘤的标准选择。最近,血流导向装置,如Pipeline栓塞装置(PED),正被广泛应用于未破裂的颅内动脉瘤,在成人中已证实其安全性和有效性;然而,其在儿科人群中的应用尚不明确。在此,我们报告一例使用PED成功治疗的小儿大脑后动脉(PCA)破裂动脉瘤患者,并对该装置在这一亚组患者中的应用现状进行文献综述。
一名4岁健康男孩因蛛网膜下腔出血就诊于急诊科。磁共振血管造影(MRA)提示右侧PCA有一个破裂的夹层动脉瘤。在与患儿父母讨论治疗方案后,选择了PED装置的超说明书使用。在发病24小时内成功植入了单个PED装置。6个月随访时,患者完全康复,改良Rankin量表评分为0,MRA显示动脉瘤完全闭塞,载瘤血管通畅。
尽管PED尚未获得美国食品药品监督管理局批准用于治疗儿童颅内动脉瘤,但文献报道该应用有良好的效果。因此,对于儿科人群中更常见的具有挑战性的病例,PED可能是一种可行的治疗选择。需要对儿科人群进行进一步研究,以确定该技术是否是治疗儿童动脉瘤的可行且持久的选择。